Just a few hundred prescribers responsible for half of U.S. opioid doses
By Lisa Rapaport (Reuters Health) – The top 1% of opioid prescribers in the U.S. are...
Read More
Reuters
Jury orders Johnson & Johnson to pay $750 million in New Jersey talc case
By Lisa Girion and Michael Erman (Reuters) – Johnson & Johnson was ordered on Thursday...
Read More
Ten U.S. refineries emitted excessive cancer-causing benzene in 2019: report
(Reuters) – Ten U.S. oil refineries, including six in Texas, released the cancer-causing...
Read More
Brazil gives big tobacco companies 30 days notice in smoking lawsuit
BRASILIA (Reuters) – The world’s largest cigarette makers, British American Tobacco...
Read MoreFirst U.S. attempt at CRISPR gene editing in cancer appears safe
By Julie Steenhuysen (Reuters Health) – The first test in the United States of the CRISPR gene-editing tool in cancer appears to be safe, but it’s too soon to know whether it’s effective, U.S. researchers...
Read MoreObesity treatment programs may boost kids’ self-esteem, body image
By Linda Carroll (Reuters Health) – Children who participate in obesity treatment programs get a benefit over and above weight loss: they may also start seeing themselves more positively, a new study suggests. Based on an...
Read MoreWeight-loss surgery tied to lowered risk of colorectal cancer
By Lisa Rapaport (Reuters Health) – Obese people who have weight-loss surgery may also lower their risk of developing colorectal cancer, a research review suggests. Obesity has long been linked to increased risk of...
Read MorePeak coronavirus? Epidemic forecasts are often wrong but can be useful
By Kate Kelland and Julie Steenhuysen LONDON/CHICAGO (Reuters) – Predicting “peak virus” is often destined to fail. But that’s not to say it is pointless. Many health, policy and economic experts...
Read More
WHO says too early to say coronavirus peaking in China
By Stephanie Nebehay GENEVA (Reuters) – The World Health Organization (WHO) said on Thursday...
Read More